Ali Siam

Chief Business Officer at Rubedo

Ali Siam has a unique combination of operating and strategy experience. He was previously CBO at Celmatix, where he led the team to multi-target R&D collaborations with Evotec SE and Bayer AG, and supported the development of their corporate and portfolio strategy. Prior to Celmatix, he led corporate strategy, R&D prioritization, portfolio strategy, and due diligence engagements for biopharma, diagnostic, healthcare services, and institutional investor clients across therapeutic areas (TAs) as a team leader at L.E.K. Consulting. He also led collaborations in a whitespace team at AbbVie, in addition to developing go-to-market, launch, and lifecycle management strategies across TAs. Ali also has strategic marketing and R&D experience from his time at Johnson & Johnson and holds an MBA from Boston College and a BS in Mechanical Engineering from Northeastern University.

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices